Levosimendan Reduces Cardiac Troponin Release After Cardiac Surgery: A Meta-analysis of Randomized Controlled Studies

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 4, 2009, Pages 474-478

  Zangrillo, Alberto ^a   Biondi Zoccai, Giuseppe ^b   Mizzi, Anna ^a   Bruno, Giovanna ^a   Bignami, Elena ^a   Gerli, Chiara ^a   De Santis, Vincenzo ^c   Tritapepe, Luigi ^c   Landoni, Giovanni ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

cardiac biomarker; cardiac surgery; inotropic drug; levosimendan; meta analysis; troponin

Indexed keywords

LEVOSIMENDAN; MILRINONE; TROPONIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; DRUG MEGADOSE; HEART PROTECTION; HEART SURGERY; HUMAN; LOW DRUG DOSE; META ANALYSIS; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; ENDPOINT DETERMINATION; HEART; HUMANS; HYDRAZONES; MYOCARDIUM; POSTOPERATIVE PERIOD; PYRIDAZINES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TREATMENT OUTCOME; TROPONIN;

EID: 67650545459     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2008.11.013     Document Type: Article

References (35)

1. Bayram M., De Luca L., Massie M.B., et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am J Cardiol 96 (2005) 47G-58G
2. Thackray S., Eastaugh J., Freemantle N., et al. The effectiveness and relative effectiveness of intravenous inotropic drugs acting through the adrenergic pathway in patients with heart failure: A meta-regression analysis. Eur J Heart Fail 4 (2002) 515-529
3. Toller W.G., and Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anestesiology 104 (2006) 556-569
4. Haikala H., Kaivola J., Nissinen E., et al. Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol 27 (1995) 1859-1866
5. Pollesello P., Ovaska M., Kaivola J., et al. Binding of a new Ca2+ sensitizer, levosimendan, to recombinant human cardiac troponin C. A molecular modelling, fluorescence probe, and proton nuclear magnetic resonance study. J Biol Chem 269 (1994) 28584-28590
6. Yokoshiki H., Katsube Y., Sunagawa M., et al. Levosimendan, a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K + channel in rat arterial myocytes. Eur J Pharmacol 333 (1997) 249-259
7. Lilleberg J., Nieminen M.S., Akkila J., et al. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary artery bypass garfting. Eur Heart J 19 (1998) 660-668
8. Barisin S., Husedzinovic I., Sonicki Z., et al. Levosimendan in off-pump coronary artery bypass: a four-time masked controlled study. J Cardiovasc Pharmacol 44 (2004) 703-708
9. Husedžinović I., Barisin S., Bradić N., et al. Levosimendan as a new strategy during off-pump coronary artery bypass grafting: Double-blind randomized placebo-controlled trial. Croat Med J 46 (2005) 950-956
10. Al-Shawaf E., Ayed A., Vislocky I., et al. Levosimendan or milrinone in the type 2 diabetic patient with low ejection fraction undergoing elective coronary artery surgery. J Cardiothorac Vasc Anesth 20 (2006) 353-357
11. Tritapepe L., De Santis V., Vitale D., et al. Preconditioning effects of levosimendan in coronary artery bypass grafting-A pilot study. Br J Anaesth 96 (2006) 694-700
12. De Hert S.G., Lorsomradee S., Cromheecke S., et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anesth Analg 104 (2007) 766-773
13. Biondi-Zoccai G.G., Agostoni P., Abbate A., et al. A simple hint to improve Robinson and Dickersin's highly sensitive PubMed search strategy for controlled clinical trials. Int J Epidemiol 34 (2005) 224-225
14. Higgins J.P.T., and Green S. The Cochrane Handbook for Systematic Reviews of Interventions 4.2.5. http://www.cochrane.org/resources/handbook/hbook.htm Accessed October 10, 2005
15. Moher D., Cook D.J., Eastwood S., et al. Improving the quality of reports of meta-analyses of randomized controlled trials: The QUOROM Statement. Quality of Reporting of Meta-analyses. Lancet 354 (1999) 1896-1900
16. Biondi-Zoccai G.G., Lotrionte M., Abbate A., et al. Compliance with QUOROM and quality of reporting of overlapping meta-analysis on the role of acetylcysteine in the prevention of contrast associated nephropathy: Case study. BMJ 332 (2006) 202-209
17. Alvarez J., Bouzada M., Fernández A.L., et al. [Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery]. Rev Esp Cardiol 59 (2006) 338-345
18. Nijhawan N., Nicolosi A.C., Montgomery M.W., et al. Levosimendan enhances cardiac performance after cardiopulmonary bypass: A prospective, randomized placebo-controlled trial. J Cardiovasc Pharmacol 34 (1999) 219-228
19. Follath F., Cleland J.G., Just H., et al., Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): A randomised double-blind trial. Lancet 360 (2002) 196-202
20. Mebazaa A., Nieminen M.S., Packer M., et al. Levosimendan vs dobutamine for patients with acute decompensated heart failure: The SURVIVE Randomized Trial. JAMA 297 (2007) 1883-1891
21. Kersten J.R., Montgomery M.W., Pagel P.S., et al. Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of K(ATP) channels. Anesth Analg 90 (2000) 5-11
22. du Toit E., Hofmann D., McCarthy J., et al. Effect of levosimendan on myocardial contractility, coronary and peripheral blood flow, and arrhythmias during coronary artery ligation and reperfusion in the in vivo pig model. Heart 86 (2001) 81-87
23. Jaffe A.S., Ravkilde J., Roberts R., et al. It's time for a change to a troponin standard. Circulation 102 (2000) 1216-1220
24. Etievent J.P., Chocron S., Toubin G., et al. Use of cardiac troponin I as a marker of perioperative myocardial ischemia. Ann Thorac Surg 59 (1995) 1192-1194
25. Chocron S., Alwan K., Toubin G., et al. Crystalloid cardioplegia route of delivery and cardiac troponin I release. Ann Thorac Surg 62 (1996) 481-485
26. Hendrikx M., Jiang H., Gutermann H., et al. Release of cardiac troponin I in antegrade crystalloid versus cold blood cardioplegia. J Thorac Cardiovasc Surg 118 (1999) 452-459
27. Fellahi J.L., Gue X., Richomme X., et al. Short- and long- term prognostic value of postoperative cardiac troponin I concentration in patients undergoing coronary artery bypass grafting. Anesthesiology 99 (2003) 270-274
28. Lasocki S., Provenchere S., Benessiano J., et al. Cardiac troponin I is an independent predictor of in-hospital death after adult cardiac surgery. Anesthesiology 97 (2002) 405-411
29. Croal B.L., Hillis G.S., Gibson P.H., et al. Relationship between postoperative cardiac troponin I levels and outcome of cardiac surgery. Circulation 114 (2006) 1468-1475
30. Birdi I., Caputo M., Hutter J.A., et al. Troponin I release during minimally invasive coronary artery surgery. J Thorac Cardiovasc Surg 114 (1997) 509-510
31. Dehoux M., Provenchère S., Benessiano J., et al. Utility of cardiac troponin measurement after cardiac surgery. Clin Chim Acta 311 (2001) 41-44
32. Hirsch R., Dent C.L., Wood M.K., et al. Patterns and potential value of cardiac troponin I elevations after pediatric cardiac operations. Ann Thorac Surg 65 (1998) 1394-1399
33. Immer F., Stocker F.P., Seiler A.M., et al. Comparison of troponin-I and troponin-T after pediatric cardiovascular operation. Ann Thorac Surg 66 (1998) 2073-2077
34. Boriani G., Biffi M., Cervi V., et al. Evaluation of myocardial injury following repeated internal atrial shocks by monitoring serum cardiac troponin I levels. Chest 118 (2000) 342-347
35. Biondi-Zoccai G.G., Agostoni P., and Abbate A. Parallel hierarchy of scientific studies in cardiovascular medicine. Ital Heart J 4 (2003) 819-820